ArcticZymes said last week that it has inked a supply agreement with GE Healthcare Life Sciences for products based on ArcticZymes' portfolio of heat-labile enzymes.
Tromsø, Norway-based ArcticZymes' heat-labile enzyme portfolio includes shrimp alkaline phosphatase, Cod-UNG, DNases and other nucleases, and kits for PCR decontamination and genomic DNA removal. The cold-adapted enzymes are particularly well-suited for molecular biology research and diagnostic applications, ArcticZymes said.
ArcticZymes, a subsidiary of Biotec Pharmacon, has previously inked similar supply agreements with New England Biolabs and Affymetrix.
Financial terms of the agreement were not disclosed.